Clinical Trial Update: Asciminib RMP Study

View source ↗

Summary

Update on Asciminib's risk management plan study for chronic myeloid leukemia; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• SCEMBLIX (ASCIMINIB)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Status: RECRUITING